The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Labskin:addl workspace at DHEZ Bradford University

21 Mar 2019 07:00

RNS Number : 4836T
Integumen PLC
21 March 2019
 

AIM share code: SKIN

 

21 March 2019

 

Integumen PLC

("Integumen" or "Company")

 

Labskin take up additional space with joint development partners at University of Bradford

 

Integumen, the AIM-quoted company, announces the further expansion of its subsidiary, Labskin, which has agreed to occupy secure workspace in the Digital Health Enterprise Zone (SHEZ) at the University of Bradford, UK in early April 2019. This is an extension to our already enlarged laboratories in York, UK.

 

This workspace affords the Labskin team close proximity to our collaboration partners at the Centre for Skin Sciences (CSS) who are based in the DHEZ and. Labskin and CSS are engaging in preliminary research, before embarking on a larger joint development project, with the support of local and national technology funding partners.

 

Gerard Brandon - CEO of Integumen plc, comments:

 

The Integumen ethos behind our plans for growth in the 21st Century draws upon a 395-year-old phrase. "No man is an island" (John Donne). Our development partners continue to grow, and we look forward to reaping the benefit of this collaboration, which represents our first external development facility within the University of Bradford and the Centre of Skin Science."

 

Contacts

 

Integumen plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 643

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker

+44 (0) 20 3621 4120

 

About Integumen:

 

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

 

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASESFLSFUSEID
Date   Source Headline
25th Jul 201811:45 amRNSTR-1: Notification of major holdings
24th Jul 20181:01 pmRNSPlacing & Subscription - Update
19th Jul 20184:24 pmRNSIssue of Equity
17th Jul 201810:21 amRNSNotice of GM
16th Jul 20187:30 amRNSRestoration - Integumen Plc
16th Jul 20187:01 amRNSPlacing and Subscription / Heads of Terms signed
16th Jul 20187:00 amRNSFinal Results
6th Jul 20187:00 amRNSUpdate - reverse takeover of Cellulac plc
29th Jun 20187:00 amRNSUpdate
16th Apr 20187:30 amRNSSuspension - Integumen Plc
16th Apr 20187:25 amRNSProposed Acquisition and Trading Update
22nd Dec 201711:07 amRNSPlacing and Trading update
22nd Dec 20177:00 amRNSLetter of Intent with Champion Shave
22nd Nov 20172:18 pmRNSTotal Voting Rights
17th Nov 20177:00 amRNSAcquisition of Stoer Skincare Range
9th Nov 20172:25 pmRNSResult of General Meeting
23rd Oct 201711:07 amRNSNotice of General Meeting
29th Sep 20177:00 amRNSHalf-year Report
13th Sep 20177:00 amRNSLicence Agreement for Botox Booster IP
24th Aug 20177:00 amRNSIntegumen strengthens IP portfolio
26th Jun 20171:31 pmRNSResult of AGM
19th Jun 20177:00 amRNSIntegumen wins new orders for Labskin
2nd Jun 20177:00 amRNSFinal Results
11th Apr 20174:15 pmRNSIssue of Equity
11th Apr 20177:00 amRNSSupply Agreement in Asia
10th Apr 20179:26 amRNSDirector/PDMR Shareholding
5th Apr 20177:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.